|
|||||
|
|
Pretransplant prophylactic rituximab to prevent Epstein‐Barr virus (EBV) viremia in EBV‐seronegative kidney transplant recipients from EBV‐seropositive donors: results of a pilot study |
|
| Authors: | Thomas Schachtner Petra Reinke |
| Affiliation: | 1. Department of Nephrology and Internal Intensive Care, Charité University Medicine Berlin, Campus Virchow Clinic, Berlin, Germany;2. Berlin‐Brandenburg Center of Regenerative Therapies (BCRT), Berlin, Germany |
| Abstract: | |
| Keywords: | CMV EBV PTLD renal transplantation rituximab |